文献速递骨肌介入

脊柱与大关节射频消融术局麻药选择:肌骨放射医师实用综述

Local anesthetic selection for spine and large joint radiofrequency ablation: a practical review for the musculoskeletal radiologist.
PubMed 文献 · Skeletal Radiol · 2026-09-15

本文综述脊柱内侧支、骶髂关节外侧支及大关节关节支射频消融术中局麻药选择。研究综合药理学数据与相邻操作文献,形成实践考虑。作者指出缺乏RFA领域随机或前瞻性对照试验,所有陈述均基于间接证据、机制推理或作者实践并逐一标注。

要点

  • 利多卡因1%可作为皮肤、皮下及深部通道麻醉的合理默认选择。
  • 感觉或运动刺激测试时,有机制理由避免在目标神经附近使用利多卡因2%。
  • 毁损前神经周围注射可合理选择布比卡因0.25%或罗哌卡因0.2%。

核心结论

  • 尚无任何专门文件涉及脊柱内侧支、骶髂关节外侧支及大周围关节关节支射频消融术的局麻药选择问题。
  • 所有陈述均基于间接证据、机制推理或作者实践,并逐一标注,缺乏RFA领域的随机或前瞻性对照试验。
  • 这些考虑旨在为实践提供参考,并推动该领域所需的前瞻性研究。

研究设计与样本

  • 本文为实用性综述,综合药理学数据与相邻操作文献形成实践考虑,未检索到RFA领域内评估局麻药种类、浓度或使用顺序的随机或前瞻性对照试验。

诊断标准与关键数值

  • 利多卡因1%作为皮肤、皮下及深部通道麻醉的合理默认选择。
  • 进行感觉和/或运动刺激测试时,有机制理由避免在目标神经附近使用利多卡因2%,因浓度升高时纤维类别间选择性下降。
  • 该机制论证来源于硬膜外定量感觉测试及啮齿动物电生理学,未经RFA验证,亦无研究显示利多卡因2%会损害刺激测试或操作结果。
  • 毁损前神经周围注射可合理选择布比卡因0.25%或罗哌卡因0.2%。
  • 预混利多卡因与布比卡因无已证实的优势:五项随机试验均不在介入疼痛治疗场景且设计异质,混合物未较单用布比卡因加速起效,且部分缩短了作用持续时间。

临床应用与阅片要点

  • 在心脏传导疾病或多节段操作中,罗哌卡因是合理的优先选择。
  • 文章提供了结构化的过敏替代路径,以正式过敏专科医师评估为核心步骤。
  • 两项试验发现同一部位先后注射不优于预混,提示无需常规采用序贯注射策略。

局限性

  • 缺乏射频消融术内评估局麻药种类、浓度或顺序的随机或前瞻性比较试验。
  • 所有陈述均依赖间接证据、机制推理或作者自身实践,证据强度有限。
  • 关于利多卡因2%影响刺激测试的论证源自硬膜外定量感觉测试及啮齿动物电生理学,未经射频消融验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Local anesthetic (LA) selection for radiofrequency ablation (RFA) of spinal medial branch nerves, sacroiliac joint lateral branches, and large peripheral joint articular branches has not been addressed by any dedicated document. The concentration, class, and sequencing of agents used during needle placement, stimulation testing, and pre-lesioning injection have plausible implications for procedural accuracy and post-procedural analgesia. This review synthesizes pharmacological data and adjacent procedural literature into practice considerations for the musculoskeletal radiologist. No randomized or prospective comparative trial has evaluated LA agents, concentrations, or sequencing within an RFA procedure; every statement therefore rests on indirect evidence, mechanistic reasoning, or the authors' practice, and each is labeled accordingly. Lidocaine 1% is a reasonable default for skin, subcutaneous, and deep track anesthesia. Where sensory and/or motor stimulation testing is performed, there is a mechanistic argument for avoiding lidocaine 2% close to the target nerve, since selectivity between fiber classes falls as concentration rises; that argument derives from epidural quantitative sensory testing and rodent electrophysiology, has not been tested in RFA, and no study has shown that lidocaine 2% impairs stimulation testing or procedural outcome. Bupivacaine 0.25% or ropivacaine 0.2% is a reasonable choice for perineural injection before lesioning. Premixing lidocaine and bupivacaine has no demonstrated advantage: across five randomized trials, all outside interventional pain settings and heterogeneous in design, mixtures did not accelerate onset relative to bupivacaine alone and in several curtailed its duration; two also found same-site sequential injection no better than premixing. Ropivacaine is a reasonable preference in cardiac conduction disease or multi-level procedures. A structured allergy substitution pathway is provided with formal allergist evaluation as the central step. These considerations are offered to inform practice and to prompt the prospective studies the field lacks.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Gonzalez, Smirniotopoulos. Local anesthetic selection for spine and large joint radiofrequency ablation: a practical review for the musculoskeletal radiologist. Skeletal Radiol. 2026. PMID: 42742682. doi:10.1007/s00256-026-05365-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。